149 related articles for article (PubMed ID: 34543659)
1. Antioxidant tempol modulates the increases in tissue nitric oxide metabolites concentrations after oral nitrite administration.
Ferreira GC; Pinheiro LC; Oliveira-Paula GH; Angelis CD; Portella RL; Tanus-Santos JE
Chem Biol Interact; 2021 Nov; 349():109658. PubMed ID: 34543659
[TBL] [Abstract][Full Text] [Related]
2. TEMPOL enhances the antihypertensive effects of sodium nitrite by mechanisms facilitating nitrite-derived gastric nitric oxide formation.
Amaral JH; Montenegro MF; Pinheiro LC; Ferreira GC; Barroso RP; Costa-Filho AJ; Tanus-Santos JE
Free Radic Biol Med; 2013 Dec; 65():446-455. PubMed ID: 23892053
[TBL] [Abstract][Full Text] [Related]
3. Oral nitrite circumvents antiseptic mouthwash-induced disruption of enterosalivary circuit of nitrate and promotes nitrosation and blood pressure lowering effect.
Pinheiro LC; Ferreira GC; Amaral JH; Portella RL; Tella SOC; Passos MA; Tanus-Santos JE
Free Radic Biol Med; 2016 Dec; 101():226-235. PubMed ID: 27769921
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive time course study of tissue nitric oxide metabolites concentrations after oral nitrite administration.
Pinheiro LC; Ferreira GC; Damacena de Angelis C; Toledo JC; Tanus-Santos JE
Free Radic Biol Med; 2020 May; 152():43-51. PubMed ID: 32151744
[TBL] [Abstract][Full Text] [Related]
5. Tempol improves xanthine oxidoreductase-mediated vascular responses to nitrite in experimental renovascular hypertension.
Oliveira-Paula GH; Pinheiro LC; Guimaraes DA; Tella SO; Blanco AL; Angelis CD; Schechter AN; Tanus-Santos JE
Redox Biol; 2016 Aug; 8():398-406. PubMed ID: 27078869
[TBL] [Abstract][Full Text] [Related]
6. Contrasting effects of low versus high ascorbate doses on blood pressure responses to oral nitrite in L-NAME-induced hypertension.
Pinheiro LC; Ferreira GC; Vilalva KH; Toledo JC; Tanus-Santos JE
Nitric Oxide; 2018 Apr; 74():65-73. PubMed ID: 29378249
[TBL] [Abstract][Full Text] [Related]
7. Membrane-permeable radical scavenger, tempol, reduces multiple organ injury in a rodent model of gram-positive shock.
Zacharowski K; Olbrich A; Cuzzocrea S; Foster SJ; Thiemermann C
Crit Care Med; 2000 Jun; 28(6):1953-61. PubMed ID: 10890647
[TBL] [Abstract][Full Text] [Related]
8. Gastric S-nitrosothiol formation drives the antihypertensive effects of oral sodium nitrite and nitrate in a rat model of renovascular hypertension.
Pinheiro LC; Amaral JH; Ferreira GC; Portella RL; Ceron CS; Montenegro MF; Toledo JC; Tanus-Santos JE
Free Radic Biol Med; 2015 Oct; 87():252-62. PubMed ID: 26159506
[TBL] [Abstract][Full Text] [Related]
9. Consistent gastric pH-dependent effects of suppressors of gastric acid secretion on the antihypertensive responses to oral nitrite.
Sanches-Lopes JM; Ferreira GC; Pinheiro LC; Kemp R; Tanus-Santos JE
Biochem Pharmacol; 2020 Jul; 177():113940. PubMed ID: 32224135
[TBL] [Abstract][Full Text] [Related]
10. Nitrite and tempol combination promotes synergic effects and alleviates right ventricular wall stress during acute pulmonary thromboembolism.
Neto-Neves EM; Sousa-Santos O; Ferraz KC; Portella RL; Sertório JT; Tanus-Santos JE
Nitric Oxide; 2021 Oct; 115():23-29. PubMed ID: 34133975
[TBL] [Abstract][Full Text] [Related]
11. Dietary nitrate increases gastric mucosal blood flow and mucosal defense.
Petersson J; Phillipson M; Jansson EA; Patzak A; Lundberg JO; Holm L
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G718-24. PubMed ID: 17082222
[TBL] [Abstract][Full Text] [Related]
12. Tempol-nebivolol therapy potentiates hypotensive effect increasing NO bioavailability and signaling pathway.
Bertera FM; Santa-Cruz DM; Balestrasse KB; Gorzalczany SB; Höcht C; Taira CA; Polizio AH
Free Radic Res; 2014 Feb; 48(2):109-18. PubMed ID: 24074298
[TBL] [Abstract][Full Text] [Related]
13. 4-Hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (Tempol) inhibits peroxynitrite-mediated phenol nitration.
Carroll RT; Galatsis P; Borosky S; Kopec KK; Kumar V; Althaus JS; Hall ED
Chem Res Toxicol; 2000 Apr; 13(4):294-300. PubMed ID: 10775330
[TBL] [Abstract][Full Text] [Related]
14. The antioxidant tempol decreases acute pulmonary thromboembolism-induced hemolysis and nitric oxide consumption.
Sousa-Santos O; Neto-Neves EM; Ferraz KC; Sertório JT; Portella RL; Tanus-Santos JE
Thromb Res; 2013 Nov; 132(5):578-83. PubMed ID: 24083962
[TBL] [Abstract][Full Text] [Related]
15. The Skeletal Muscle, the Heart, and the Liver Are the Major Organs of the Accumulation of Nitric Oxide Metabolites after Oral Nitrite Treatment.
Lima-Silva AK; Rebelo MA; Barros AC; Conde-Tella SO; Tanus-Santos JE
Antioxidants (Basel); 2024 Feb; 13(3):. PubMed ID: 38539788
[TBL] [Abstract][Full Text] [Related]
16. Effects of diet on measurement of nitric oxide metabolites.
Wang J; Brown MA; Tam SH; Chan MC; Whitworth JA
Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):418-20. PubMed ID: 9171946
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity.
Campese VM; Ye S; Zhong H; Yanamadala V; Ye Z; Chiu J
Am J Physiol Heart Circ Physiol; 2004 Aug; 287(2):H695-703. PubMed ID: 15277201
[TBL] [Abstract][Full Text] [Related]
18. Ethyl nitrite is produced in the human stomach from dietary nitrate and ethanol, releasing nitric oxide at physiological pH: potential impact on gastric motility.
Rocha BS; Gago B; Barbosa RM; Cavaleiro C; Laranjinha J
Free Radic Biol Med; 2015 May; 82():160-6. PubMed ID: 25645954
[TBL] [Abstract][Full Text] [Related]
19. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
García-Calderó H; Rodríguez-Vilarrupla A; Gracia-Sancho J; Diví M; Laviña B; Bosch J; García-Pagán JC
J Hepatol; 2011 Apr; 54(4):660-5. PubMed ID: 21159403
[TBL] [Abstract][Full Text] [Related]
20. Effects of local administrations of tempol and diethyldithio-carbamic on peripheral nerve activity.
Shokoji T; Fujisawa Y; Kimura S; Rahman M; Kiyomoto H; Matsubara K; Moriwaki K; Aki Y; Miyatake A; Kohno M; Abe Y; Nishiyama A
Hypertension; 2004 Aug; 44(2):236-43. PubMed ID: 15262907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
